These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 12201241)

  • 21. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
    Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
    Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The maturation of differentiation therapy.
    Cheson BD
    N Engl J Med; 1992 Aug; 327(6):422-4. PubMed ID: 1625719
    [No Abstract]   [Full Text] [Related]  

  • 23. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
    Wang Z; Sun G; Shen Z; Chen S; Chen Z
    Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hot on the TRAIL of acute promyelocytic leukemia.
    Zelent A
    Nat Med; 2001 Jun; 7(6):662-4. PubMed ID: 11385499
    [No Abstract]   [Full Text] [Related]  

  • 25. UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia.
    Kitareewan S; Pitha-Rowe I; Sekula D; Lowrey CH; Nemeth MJ; Golub TR; Freemantle SJ; Dmitrovsky E
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3806-11. PubMed ID: 11891284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia.
    Luesink M; Jansen JH
    Br J Haematol; 2010 Nov; 151(3):209-20. PubMed ID: 20735400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antileukemic effect of paclitaxel in combination with metformin in HL-60 cell line.
    Asik A; Kayabasi C; Ozmen Yelken B; Yılmaz Susluer S; Dogan Sigva ZO; Balcı Okcanoglu T; Saydam G; Biray Avci C; Gunduz C
    Gene; 2018 Mar; 647():213-220. PubMed ID: 29309887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells.
    Wang S; Zhou M; Ouyang J; Geng Z; Wang Z
    PLoS One; 2015; 10(6):e0130343. PubMed ID: 26110921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Over-expression of Mcl-1 impairs the ability of ATRA to induce growth arrest and differentiation in acute promyelocytic leukemia cells.
    Yang J; Ikezoe T; Nishioka C; Yokoyama A
    Apoptosis; 2013 Nov; 18(11):1403-1415. PubMed ID: 23760752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome‑wide profiling of lncRNA expression patterns in patients with acute promyelocytic leukemia with differentiation therapy.
    Yu J; Guo XL; Bai YY; Yang JJ; Zheng XQ; Ruan JC; Chen ZG
    Oncol Rep; 2018 Sep; 40(3):1601-1613. PubMed ID: 29956795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation therapy in acute promyelocytic leukemia: European experience.
    Degos L
    J Cell Physiol; 1997 Nov; 173(2):285-7. PubMed ID: 9365538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells.
    Meyer PN; Roychowdhury S; Kini AR; Alkan S
    Leuk Res; 2008 Jan; 32(1):143-9. PubMed ID: 17617451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Terminal differentiation of human acute promyelocytic leukemia (APL) cells induced by Tanshinone II A in primary culture].
    Liang Y; Yang Y; Yuan S; Liu T; Jia Y; Xu C; Niu T; Qin H; Qin P
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):207-10. PubMed ID: 12515138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Induction of differentiation of human leukemia cells].
    Kizaki M; Nakajima H; Ikeda Y
    Hum Cell; 1992 Jun; 5(2):103-9. PubMed ID: 1382572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cell differentiation and apoptosis of tumor cells].
    Zhang T
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 May; 19(5):261-2. PubMed ID: 11783236
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?
    Dombret H; Geiger S; Daniel MT; Glaisner S; Micléa JM; Castaigne S; Merle-Beral H; Lacombe C; Chomienne C; Degos L
    Leukemia; 1995 Sep; 9(9):1473-7. PubMed ID: 7658714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent effects of selenite (Se(4+)) on arsenite (As(3+))-induced apoptosis and differentiation in acute promyelocytic leukemia cells.
    Wang S; Geng Z; Shi N; Li X; Wang Z
    Cell Death Dis; 2015 Jan; 6(1):e1596. PubMed ID: 25590806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
    Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H
    Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.